Vertex Pharmaceuticals
VRTX
VRTX
695 hedge funds and large institutions have $46.6B invested in Vertex Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 253 increasing their positions, 247 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 253 | Existing positions reduced: 247
0.01% more ownership
Funds ownership: 94.72% → 94.73% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
Holders
695
Holding in Top 10
16
Calls
$403M
Puts
$352M
Top Buyers
| 1 | +$554M | |
| 2 | +$512M | |
| 3 | +$330M | |
| 4 |
Jennison Associates
New York
|
+$220M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$135M |
Top Sellers
| 1 | -$635M | |
| 2 | -$207M | |
| 3 | -$155M | |
| 4 |
Goldman Sachs
New York
|
-$144M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$134M |